Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 37: 882-886, 1991;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cassulis, P.
Right arrow Articles by DeBari, V. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cassulis, P.
Right arrow Articles by DeBari, V. A.

Clinical Chemistry, Vol 37, 882-886, Copyright © 1991 by American Association for Clinical Chemistry

Ligand affinity chromatographic separation of serum IgG on recombinant protein G-silica

P Cassulis, MV Magasic and VA DeBari
Department of Medicine, Seton Hall University, School of Graduate Medical Education.

We purified IgG by an automated chromatographic procedure, using a recombinant DNA-produced Protein G ligand bound to silica as the solid phase. The IgG can be separated from human serum in approximately 20 min with little operator manipulation. Recovery studies indicate that unconcentrated eluates contain 77-100% of the applied IgG. Concentration to volumes approximating that of the applied serum resulted in recovery of 76-98% of the applied IgG. High-resolution protein electrophoresis of the eluates demonstrated retention of the broad gamma band, with virtual absence of other serum proteins. This finding was confirmed by immunoelectrophoresis, which demonstrated homogeneity of IgG in the eluates. IgG subclass distributions in four eluates, compared with the sera from which they were harvested, indicate comparable percentages of IgG1, IgG2, and IgG3 and some enhancement of the IgG4 fraction [serum IgG4: 2.9 +/- 0.4% (SEM); eluate IgG4: 13.8 +/- 1.7%, P = 0.007]. The reactivity of eluates from two sera containing various antibodies to human immunodeficiency virus type 1 was virtually identical to that of the sera from which they were prepared. We conclude that this chromatographic application is an effective purification method for serum IgG and antibodies of the IgG class. The method may be applicable in the specialty clinical laboratory, particularly in those interested in protein and other immunological abnormalities.


The following articles in journals at HighWire Press have cited this article:


Home page
 Clin. Chem.Home page
D. S. Hage
Affinity Chromatography: A Review of Clinical Applications
Clin. Chem., May 1, 1999; 45(5): 593 - 615.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1991 by the American Association for Clinical Chemistry.